当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析

南京医药

(600713)

  

流通市值:64.47亿  总市值:65.58亿
流通股本:12.87亿   总股本:13.09亿

南京医药(600713)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.80亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益785399.47万元,未分配利润271907.55万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产3320579.51万元,负债2535180.05万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入27,967,411,701.6214,246,884,352.753,696,173,895.840,938,180,822.52
营业总成本27,397,599,436.3113,943,368,597.8352,651,384,912.8840,123,096,334.31
其他经营收益
营业利润508,182,105.47274,943,946.691,023,404,107.29771,608,225.76
利润总额526,853,483.18276,335,599.731,003,395,388.5762,554,430.98
净利润379,749,529.44215,583,457.34743,119,993.89563,806,536.98
每股收益
其他综合收益-1,489,536.52-7,229,191.8512,772,851.8628,155,158.32
综合收益总额378,259,992.92208,354,265.49755,892,845.75591,961,695.3
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计30,188,607,618.6430,516,521,104.427,807,861,740.629,634,677,935.52
非流动资产:
非流动资产合计3,017,187,526.332,962,928,150.982,865,765,191.922,819,429,303.74
资产总计33,205,795,144.9733,479,449,255.3830,673,626,932.5232,454,107,239.26
流动负债:
流动负债合计20,696,678,755.5819,627,239,754.7617,093,712,526.9119,729,664,496.28
非流动负债:
非流动负债合计4,655,121,729.735,845,649,822.235,792,016,291.65,178,146,355.71
负债合计25,351,800,485.3125,472,889,576.9922,885,728,818.5124,907,810,851.99
所有者权益(或股东权益):
归属于母公司股东权益合计6,859,580,954.357,018,676,593.36,838,027,007.126,712,269,732.43
股东权益合计7,853,994,659.668,006,559,678.387,787,898,114.017,546,296,387.27
负债和股东权益合计33,205,795,144.9733,479,449,255.3830,673,626,932.5232,454,107,239.26
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计24,033,009,722.7311,984,973,339.1556,586,023,183.939,191,120,886.11
经营活动现金流出小计28,064,489,463.1115,585,412,464.5554,450,257,768.542,084,952,655.7
经营活动产生的现金流量净额-4,031,479,740.38-3,600,439,125.42,135,765,415.4-2,893,831,769.59
投资活动产生的现金流量:
投资活动现金流入小计835,917,651.47970,426.9610,434,012.426,891,335.59
投资活动现金流出小计1,049,494,571407,566,651.24572,360,104.06503,800,439.59
投资活动产生的现金流量净额-213,576,919.53-406,596,224.28-561,926,091.64-496,909,104
筹资活动产生的现金流量:
筹资活动现金流入小计14,998,953,182.938,435,822,069.1921,178,888,465.4116,187,660,700.86
筹资活动现金流出小计12,001,819,598.685,655,040,239.5822,018,660,463.4814,187,678,325.93
筹资活动产生的现金流量净额2,997,133,584.252,780,781,829.61-839,771,998.071,999,982,374.93
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,247,923,075.66-1,226,253,520.07734,067,325.69-1,390,758,498.66
期末现金及现金等价物余额1,680,213,380.891,701,882,936.482,928,136,456.55803,310,632.2
补充资料:
现金及现金等价物的净增加额-1,247,923,075.66-734,067,325.69-
TOP↑